608
RATHOD ET AL.
[7] a) F. Bossert, H. Meyer, E. Wehinger, Angew. Chem. Int. Ed.
1981, 20, 762. b) H. Nakayama, Y. Kasoaka, Heterocycles 1996,
42, 901.
[8] a) T. Godfraid Miller, R. Wibo, Pharmocol. Rev. 1986, 38, 321.
b) A. Sausins, G. Duburs, Heterocycles 1988, 27, 269. c) P. P.
Mager, R. A. Coburn, A. J. Solo, D. J. Triggle, H. Rothe, Drug
Des. Discov. 1992, 8, 273. d) R. Mannhold, B. Jablonka, W.
Voigdt, K. Schoenafinger, K. Schravan, Eur. J. Med. Chem.
1992, 27, 229.
aldehyde to form intermediate (I) and with ethyl
acetoacetate and ammonium acetate to form intermediate
(II). Intermediates I and II undergo cyclocondensation to
obtain the final desired product (Scheme 2).
To specify the advantage of the defined methodology,
the results of different reported methods are compared
with our results and summarized in Table 5. It was
observed from the tabulated results that the IRMOF-3
catalyst promoted the reaction more effectively than
other reported methods.
[9] a) F. R. Buhler, W. J. Kiowski, Hypertens 1987, 5, S3. b) J. L.
Reid, P. A. Meredith, F. J. Pasanisi, Cardiovasc. Pharmacol.
1985, 7, S18.
[10] W. M. Cholody, B. Horowska, J. Paradziej-Lukowicz, S.
Martelli, J. Konopa, J. Med. Chem. 1996, 39, 1028.
[11] a D. Mauzeral, F. H. Westheimer, J. Am. Chem. Soc. 1955, 77,
2261. b P. G. Baraidi, A. Chiarini, R. Budriesi, M. Roberti, A.
Casolar, S. Manfredini, D. Simoni, V. Zanirato, K. Varani, P.
Borea, Drug Des. Deliv. 1989, 5, 57, 13. c P. G. Baraldi, R.
Budriesi, B. Cacciari, A. Chaiarini, L. Garuti, G. Giovanninetti,
A. Leoni, M. Roberti, Collect. Czech. Chem. Commun. 1992,
169. d A. DiStilo, S. Visentin, C. Clara, A. M. Gasco, G.
Ermondi, A. Gasco, J. Med. Chem. 1998, 41, 5393. e M.
Kawase, A. Shah, H. Gaveriya, N. Motohashi, H. Sakagami, A.
Varga, J. Molnar, J. Bioorg. Chem. 2002, 10, 1051. f M. Suarez,
Y. Verdecia, B. Illescas, R. Martinez-Alvarez, A. Avarez, E.
Ochoa, C. Seoane, N. Kayali, N. Martin, Tetrahedron 2003, 59,
9179. g R. Shan, C. Velazquez, E. Knaus, J. Med. Chem. 2004,
47, 254. h Y. Sawada, H. Kayakiri, Y. Abe, T. Mizutani, N.
Inamura, M. Asano, C. Hatori, I. Arsmori, T. Oku, H. Tanaka,
J. Med. Chem. 2853, 2004, 47.
4 | CONCLUSIONS
In summary, we have synthesized a mesoporous IRMOF-3
MOF catalyst using the solvothermal method. Efficient
catalytic activity has been developed for the synthesis
of polyhydroquinoline derivatives via the Hantzsch
condensation reaction. In the IRMOF-3 catalyst, there is
organization between the Lewis acidic site and rigid NH2-
benzenedicarboxylate linking in the zinc-based MOF
cluster. XRD, IR, BET, SEM analysis confirm the tetra-
gonal phase, greater porediameter, morphology observed
crystalline and irregular duab shape and it has no signifi-
cance loss of catalytic activity when used in organic trans-
formation for three to four run. This method offers
remarkable benefits over other reported methods, for
example, easy to separate, reusable catalytic characters,
nontoxic, short reaction time, large pore size, and provided
excellent yield of polyhydroquinoline derivatives (5a–j).
[12] L. Nagarapu, S. Apuri, S. Gaddam, R. Bantu, V. C. M. S.
Kantevari, Lett. Org. Chem. 2008, 5, 60.
[13] M. Maheswara, V. Siddaiah, G. L. V. Damu, C. V. Rao,
ARKIVOC 2006, 2006, 201.
[14] S.-J. Ji, Z.-Q. Jiang, J. Lu, T.-P. Loh, Synth. Lett. 2004, 5, 831.
[15] M. M. Heravi, K. Bakhtiri, N. M. Javadi, F. F. Bamoharram,
M. Saeedi, H. A. Oskooi, J. Mol. Catal. A: Chem. 2007,
264, 50.
[16] H. Adibi, H. A. Samimi, M. Beygzadeh, Catal. Commun. 2007,
8, 2119.
[17] G. Sabitha, K. K. Reddy, C. S. Reddy, J. S. Yadav, Tetrahedron
Lett. 2003, 44, 4129.
[18] B. Das, B. Ravikanth, R. Ramu, B. Vittal Rao, Chem. Pharm.
Bull. 2006, 54, 1044.
ACKNOWLEDGMENTS
We are thankful to the head of the chemistry department,
Dr. Babashaheb Marathwada, University Aurangabad
(MS)-431004, India for providing necessary laboratory
facilities and to SAIF Chandigarh, SAIF STIC Cochin,
and SAIF Lucknow for characterization facilities. One of
the authors, VNR, is thankful to UGC Delhi for providing
faculty improvement programmers (FIP).
[19] L. M. Wang, J. Sheng, L. Zhang, J. W. Han, Z. Y. Fan, H. Tian,
C. T. Qian, Tetrahedron 2005, 61, 1539.
[20] S. Rostamnia, H. Xin, Appl. Organometal. Chem. 2014, 28, 359.
[21] S. J. Ji, Z. Q. Jiang, J. Lu, T. P. Loa, Synth. Lett. 2004,
831, 831.
[22] J. B. Sainani, A. C. Shah, V. P. Arya, Indian J. Chem. 1994,
33, 526.
[23] L. J. Donelson, A. R. Gibbs, K. S. De, J. Mol. Catal. A 2006,
256, 309.
[24] S. Ko, V. N. M. Sastry, C. Lin, F. C. Yao, Tetrahedron Lett.
2005, 46, 5771.
[25] F. Matloubi Moghaddam, H. Saeidian, Z. Mirjafary, A.
Sadeghi, J. Iran. Chem. Soc. 2009, 6, 317.
[26] N. N. Karade, V. H. Budhewar, S. V. Shinde, W. N. Jadhav,
Lett. Org. Chem. 2007, 4, 16.
REFERENCES
[1] H. Furukawa, K. E. Cordova, M. O'Keeffe, O. M. Yaghi, Sci-
ence 2013, 341, 974.
[2] Y. Ye, S. Xiong, X. Wu, L. Zhang, Z. Li, L. Wang, X. Ma,
Q.-H. Chen, Z. Zhang, S. Xiang, Inorg. Chem. 2016,
55, 292.
[3] K. Uemura, K. Saito, S. Kitagawa, H. Kita, J. Am. Chem. Soc.
2006, 128, 16122.
[4] E. A. Hall, L. R. Redfern, M. H. Wang, K. A. Scheidt, ACS
Catal. 2016, 6, 3248.
[5] A. H. Chughtai, N. Ahmad, H. A. Younus, A. Laypkov, F.
Verpoort, Chem. Soc. Rev. 2015, 44, 6804.
[6] S. A. Khedkar, P. B. Auti, Med. Chem. 2014, 14, 282.